ArticleBlood cancer journal2026

Efficacy and safety of short-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia.

Ge Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.